Methods of evaluating immunotoxicity

Bibliography

• MEYLERS L: Cytostatic drugs. In: Side-Effects of Drugs, 2nd edition. L Meylers (Ed.), Excerpta Medica, Amsterdam, The Netherlands (1966):472-494.
   Google Scholar
• VOS JG: Immune suppression as related to toxicology. CRC Crit. Rev. Toxicol. (1977) 5(1):67-101.
   PubMed Web of Science ®Google Scholar
• DEAN JH, PADARATHSINGH ML, JERRELLS TR: Assessment of immunobiological effects induced by chemicals, drugs and food additives. I. Tier testing and screening approach. Drug Chem. Toxicol. (1979) 2(1-2):5-17.
   PubMed Web of Science ®Google Scholar
• LUSTER MI, MUNSON AE, THOMASPT et al.: Development of a testing battery to assess chemical-induced immunotoxicity: National Toxicology Programs guidelines for immunotoxicity evaluation in mice. Fund. Appl. Toxicol. (1988) 10(1):2-19.
   PubMedGoogle Scholar
• WHITE KL, GRENNINGS C, MURRAYMJ, DEAN JH: Summary of an international methods validation study, carried out in nine laboratories, on the immunological assessment of cyclosporine A in the Fischer 344 rat. Toxicol. In Vitro (1994) 8(5):957-961.
   PubMed Web of Science ®Google Scholar
• RICHTER-REICHHELM HB, DASENBROCK CA, DESCOTES G et al.: Validation of a modified 28-day rat study to evidence effects of test compounds on the immune system. Regul. Toxicol. Pharmacol. 22(1):54-56.
   PubMed Web of Science ®Google Scholar
• THE ICICIS GROUP INVESTIGATORS: Report of validation study of assessment of direct immunotoxicity in the rat. Toxicology (1998) 125(2-3):183-201.
   PubMed Web of Science ®Google Scholar
• BEHAN PO, BEHAN WMH, ZACHARIAS FJ, NICHOLLS JT: Immunological abnormalities in patients who had the oculomucocutaneous syndrome associated with practolol therapy. Lancet (1976) 2(7993):984-987.
   PubMed Web of Science ®Google Scholar
• POSADA DE LA PAZ M, PHILEN RM, BORDA AI: Toxic oil syndrome: the perspective after 20 years. Epidemiol. Rev. (2001) 23(2):231-247.
   PubMed Web of Science ®Google Scholar
• KIMBER I, MAURER T: Toxicology of Contact Hypersensitivity. Taylor & Francis, London, UK (1996).
   Google Scholar
• RATAJCZAK HV: Drug-induced hypersensitivity: role in drug development. Toxicol. Rev. (2004) 23(4):265-280.
   PubMedGoogle Scholar
• VIAL T, CHOQUET-KASTYLEVSKY G, DESCOTES J: Adverse effects of immuno-therapeutics involving the immune system. Toxicology (2002) 174(1):3-11.
   PubMed Web of Science ®Google Scholar
• DESCOTES J: Regulatory aspects of immunotoxicity evaluation. In: Immunotoxicology of Drugs and Chemicals. An Experimental and Clinical Approach. Vol. 1: Principles and Methods of Immunotoxicology. J Descotes (Ed.), Elsevier Science, Amsterdam, The Netherlands (2004):257-268.
   Google Scholar
• FISHMAN JA, RUBIN RH: Infection in organ-transplant recipients. N. Engl. J. Med. (1998) 338(24):1741-1751.
   PubMed Web of Science ®Google Scholar
• KLEIN NC, GO CH, CUNHA BA: Infections associated with steroid use. Infect. Dis. Clin. North Am. (2001) 15(2):423-432.
   PubMed Web of Science ®Google Scholar
• GILES JT, BATHON JM: Serious infections associated with anticytokine therapies in the rheumatic diseases. J. Intensive Care Med. (2004) 19(6):320-334.
   PubMedGoogle Scholar
• VIAL T, DESCOTES J: Immunosuppressive drugs and cancer. Toxicology (2003) 185(3):229-240.
   PubMed Web of Science ®Google Scholar
• GEORGESCU L, PAGET SA: Lymphoma in patients treated with rheumatoid patients. What is the evidence of link with methotrexate? Drug Saf. (1999) 20(6):475-487.
   PubMed Web of Science ®Google Scholar
• BROWN SL, GREENE MH, GERSHONSK, EDWARDS ET, BRAUNMM: Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration. Arthritis Rheum. (2002) 46(12):3151-3158.
   PubMed Web of Science ®Google Scholar
• MURRAY PG, YOUNG LS: EpsteinBarr virus infection: basis of malignancy and potential for therapy. Expert Rev. Mol. Med. (2001) 3:1-20.
   PubMedGoogle Scholar
• DESCOTES J, VIAL T: Acute cytokine syndrome. In: Cytokines in Human Health: Immunotoxicology, Pathology and Therapeutic Applications. RV House, J Descotes (Eds.), Humana Press (In Press).
   Google Scholar
• KRAUSE I, VALESINI G, SCRIVO R, SHOENFELD Y: Autoimmune aspects of cytokine and anticytokine therapies. Am. J. Med. (2003) 115(5):390-397.
   PubMed Web of Science ®Google Scholar
• SHULMAN KL, THOMPSON JA, BENYUNES MC, WINTER TC, FEFERA: Adverse reactions to intravenous contrast media in patients treated with interleukin-2. J. Immunother. (1993) 13(3):208-212.
   Web of Science ®Google Scholar
• RENTON KW: Hepatic drug metabolism and immunostimulation. Toxicology (2000) 142(3):173-178.
   PubMed Web of Science ®Google Scholar
• GOMES ER, DEMOLY P: Epidemiology of hypersensitivity drug reactions. Curr. Opin. Allergy Clin. Immunol. (2005) 5(4):309-316.
   PubMed Web of Science ®Google Scholar
• CHOQUET-KASTYLEVSKY G, VIAL T, DESCOTES J: Drug allergy diagnosis in humans: possibilities and pitfalls. Toxicology (2001) 158(1-2):1-10.
   PubMed Web of Science ®Google Scholar
• JOHANSSON SG, HOURIHANE JO, BOUSQUET J et al.: A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy (2001) 56(9):813-824.
   PubMed Web of Science ®Google Scholar
• DESHAZO RD, KEMP SF: Allergic reactions to drugs and biologic agents. JAMA (1997) 278(22):1895-1906.
   PubMed Web of Science ®Google Scholar
• DESCOTES J, CHOQUET-KASTYLEVSKY G: Gell and Coombs classification: is it still valid? Toxicology (2001) 158(1-2):43-49.
   PubMed Web of Science ®Google Scholar
• NAISBITT DJ, WILLIAMS DP, PIRMOHAMED M, KITTERINGHAMNR, PARK BK: Reactive metabolites and their role in drug reactions. Curr. Opin. Allergy Clin. Immunol. (2001) 1(4):317-325.
   PubMed Web of Science ®Google Scholar
• BRITSCHGI M, VON GREYERZ S, BURKHART C, PICHLER WJ: Molecular aspects of drug recognition by specific T cells. Curr. Drug Targets (2003) 4(1):1-11.
   PubMed Web of Science ®Google Scholar
• DESCOTES J, PAYEN C, VIAL T: Pseudoallergic drug reactions. Persp. Exp. Clin. Immunotoxicol. (2006) 1(2) (In Press).
   Google Scholar
• VIAL T, NICOLAS B, DESCOTES J: Drug-induced autoimmunity: experience of the French Pharmacovigilance system. Toxicology (1997) 119(1):23-27.
   PubMed Web of Science ®Google Scholar
• D'CRUZ D: Autoimmune diseases associated with drugs, chemicals and environmental factors. Toxicol. Lett. (2000) 15(112-113):421-432.
   Web of Science ®Google Scholar
• VERDIER F, AUJOULAT M, CONDEVAUX F, DESCOTES J: Determination of lymphocyte subsets and cytokine levels in cynomolgus monkeys. Toxicology (1995) 105(1):81-90.
   PubMed Web of Science ®Google Scholar
• THIEM PA, HALPER LK, BLOOM JC: Techniques for assessing canine mononuclear phagocyte function as part of an immunotoxicologic evaluation. Int. J. Immunopharmacol. (1988) 10(6):765-771.
   PubMed Web of Science ®Google Scholar
• FINCO-KENT D, KAWABATA T: Development and validation of a canine T-cell-dependent antibody response model for immunotoxicity evaluation. J. Immunotoxicol. (2005) 2(4):197-201.
   PubMedGoogle Scholar
• HINTON DM: US FDA "Redbook II" immunotoxicity testing guidelines and research in immunotoxicity evaluations of food chemicals and new food proteins. Toxicol. Pathol. (2000) 28(3):467-478.
   PubMed Web of Science ®Google Scholar
• BASKETTER DA, BREMMER JN, BUCKLEY P et al.: Pathology considerations for, and subsequent risk assessment of, chemicals identified as immunosuppressive in routine toxicology. Food Chem. Toxicol. (1995) 33(3):239-243.
   PubMed Web of Science ®Google Scholar
• GOPINATH C: Pathology of toxic effects on the immune system. Inflamm. Res. (1996) 2(Suppl):74-78.
   Google Scholar
• CREVEL RW, BUCKLEY P, ROBINSONJA, SANDERS IJ: Immunotoxicological assessment of cyclosporin A by conventional pathological techniques and immune function testing in the rat. Hum. Exp. Toxicol. (1997) 16(2):79-88.
   PubMed Web of Science ®Google Scholar
• PUTMAN E, VAN LOVEREN H, BODEG et al.: Assessment of the immunotoxic potential of human pharmaceuticals: a workshop report. Drug Information J. (2002) 36(2):417-427.
   Web of Science ®Google Scholar
• GERMOLEC DR, KASHON M, NYSKAA et al.: The accuracy of extended histopathology to detect immunotoxic chemicals. Toxicol. Sci. (2004) 82(2):504-514.
   PubMed Web of Science ®Google Scholar
• KUPER CF, HARLEMAN JH, RICHTER-REICHELM HB, VOS JG: Histopathologic approaches to detect changes indicative of immunotoxicity. Toxicol. Pathol. (2000) 28(3):454-466.
   PubMed Web of Science ®Google Scholar
• HALEY P, PERRY R, ENNULAT D et al.: STP position paper: best practice guideline for the routine pathology evaluation of the immune system. Toxicol. Pathol. (2005) 33(3):404-407.
   PubMed Web of Science ®Google Scholar
• LUSTER MI, PORTIER C, PAIT DG et al.: Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests. Fundam. Appl. Toxicol. (1992) 18(2):200-210.
   PubMedGoogle Scholar
• SCHULTE A, ALTHOFF J, EWE S, RICHTER-REICHHELM HB; BGVV GROUP INVESTIGATORS: Two immunotoxicity ring studies according to OECD TG 407 comparison of data on cyclosporin A and hexachlorobenzene. Regul. Toxicol. Pharmacol. (2002) 36(1):12-21.
   PubMed Web of Science ®Google Scholar
• GORE ER, GOWER J, KURALI E et al.: Primary antibody response to keyhole limpet hemocyanin in rat as a model for immunotoxicity evaluation. Toxicology (2004) 197(1):23-35.
   PubMed Web of Science ®Google Scholar
• ULRICH P, PAUL G, PERENTES E, MAHL A, ROMAN D: Validation of immune function testing during a 4-week oral toxicity study with FK-506. Toxicol. Lett. (2004) 149(1-3):123-131.
   PubMed Web of Science ®Google Scholar
• PICCOTTI JR, ALVEY JD, REINDEL JF, GUZMAN RE: T-cell-dependent antibody response: assay development in cynomolgus monkeys. J. Immunotoxicol. (2005) 2(4):191-196.
   PubMedGoogle Scholar
• IMMUNOTOXICOLOGY TECHNICAL COMMITTEE, INTERNATIONAL LIFE SCIENCES INSTITUTE AND ENVIRONMENTAL SCIENCES INSTITUTE: Application of flow cytometry to immunotoxicity testing: summary of a workshop. Toxicology (2001) 163(1):39-48.
   PubMed Web of Science ®Google Scholar
• BURCHIEL SW, LAUER FT, GURULED, MOUNHO BJ, SALAS VM: Uses and future applications of flow cytometry in immunotoxicity testing. Methods (1999) 19(1):28-35.
   PubMed Web of Science ®Google Scholar
• DESCOTES J, RAVEL G: Role of NK cells in immunotoxicity: an update. Exp. Rev. Clin. Immunol. (2005) 1(4):605-610.
   Google Scholar
• SMIALOWICZ RJ: In vitro lymphocyte proliferation assays: the mitogen-stimulated response and the mixed-lymphocyte reaction in immunotoxicity testing. In: Methods in Immunotoxicology, Volume 1. GR Burleson, JH Dean, AE Munson (Eds), Wiley-Liss, New York, US (1995):197-210.
   Google Scholar
• WILKINSON PC: Assays of leukocyte locomotion and chemotaxis. J. Immunol. Methods. (1998) 216(1-2):139-153.
   PubMed Web of Science ®Google Scholar
• LEHMANN AK, SORNES S, HALSTENSEN A: Phagocytosis: measurement by flow cytometry. J. Immunol. Methods. (2000) 243(1-2):229-242.
   PubMed Web of Science ®Google Scholar
• BIENVENU JA, MONNERET G, GUTOWSKI MC, FABIEN N: Cytokine assays in human sera and tissues. Toxicology. (1998) 129(1):55-61.
   PubMed Web of Science ®Google Scholar
• HOUSE RV: Theory and practice of cytokine assessment in immunotoxicology. Methods (1999) 19(1):17-27.
   PubMed Web of Science ®Google Scholar
• DELARCHE C, CHOLLET-MARTIN S: Plasma cytokines: what we are measuring. Curr. Opin. Clin. Nutr. Metab. Care (1999) 2(6):475-479.
   PubMedGoogle Scholar
• THOMAS PT, SHERWOOD RL: Host resistance models in immunotoxicology. In: Experimental Immunotoxicology. RJ Smialowicz, MP Holsapple (Eds), CRC Press, Boca Raton, FL, USA (1996):29-45.
   Google Scholar
• DESCOTES J: Nonclinical evaluation of unexpected immunostimulation. In: Immunotoxicology of Drugs and Chemicals. An Experimental and Clinical Approach. Vol. 1: Principles and Methods of Immunotoxicology. J Descotes (Ed.), Elsevier Science, Amsterdam, The Netherlands (2004):205-218.
   Google Scholar
• HENRY SP, TAYLOR J, MIDGLEY L, LEVIN AA, KORNBRUST DJ: Evaluation of the toxicity of ISIS 2302, a phosphorothioate oligonucleotide, in a 4-week study in CD-1 mice. Antisense Nucleic Acid Drug Dev. (1997) 7(5):473-481.
   PubMedGoogle Scholar
• FARINE JC: Animal models of autoimmune disease in immunotoxicity assessment. Toxicology (1997) 119(1):29-35.
   PubMed Web of Science ®Google Scholar
• OSHIRO Y, MORRIS DL: TNF- release from human peripheral blood mononuclear cells to predict the proinflammatory properties of cytokines and growth factors. J. Pharmacol. Toxicol. Meth. (1997) 37(1):55-59.
   PubMed Web of Science ®Google Scholar
• CHOQUET-KASTYLEVSKI G, DESCOTES J: Value of animal models for predicting hypersensitivity reactions to medicinal products. Toxicology (1998) 129(1):27-35.
   PubMed Web of Science ®Google Scholar
• BALA S, WEAVER J, HASTINGS KL: Clinical relevance of preclinical testing for allergic side effects. Toxicology (2005) 209(2):195-200.
   PubMed Web of Science ®Google Scholar
• VERDIER F, CHAZAL I, DESCOTES J: Anaphylaxis models in the guinea-pig. Toxicology (1994) 93(1):55-61.
   PubMed Web of Science ®Google Scholar
• KIMBER I, DEARMAN RJ: Toxicology of Chemical Respiratory Hypersensitivity. Taylor & Francis, London, UK (1997).
   Google Scholar
• KNIPPELS LM, PENNINKS AH: Assessment of the allergic potential of food protein extracts and proteins on oral application using the Brown Norway rat model. Environ Health Perspect. (2003) 111(2):233-238.
   PubMed Web of Science ®Google Scholar
• KIMBER I, DEARMAN RJ, BASKETTERDA, RYAN CA, GERBERICK GF: The local lymph node assay: past, present and future. Contact Derm. (2002) 47(6):315-328.
   PubMed Web of Science ®Google Scholar
• BASKETTER DA, SELBIE E, SCHOLESEW, LEES D, KIMBER I, BOTHAM PA: Results with OECD recommended positive control sensitizers in the maximization, Buehler and local lymph node assays. Food Chem. Toxicol. (1993) 31(1):63-67.
   PubMed Web of Science ®Google Scholar
• WEAVER JL, STATEN D, SWANN J, ARMSTRONG G, BATES M, HASTINGS KL: Detection of systemic hypersensitivity to drugs using standard guinea pig assays. Toxicology (2003) 193(3):203-217.
   PubMed Web of Science ®Google Scholar
• WEAVER JL, CHAPDELAINE JM, DESCOTES J et al.: Evaluation of a lymph node proliferation assay for its ability to detect pharmaceuticals with potential to cause immune-mediated drug reactions. J. Immunotoxicol. (2005) 2(1):11-20.
   PubMedGoogle Scholar
• HISATOMI A, KIMURA M, MAEDA M, MATSUMOTO M, OHARA K, NOGUCHI H: Toxicity of polyoxyethylene hydrogenated castor oil 60 (HCO-60) in experimental animals. J. Toxicol. Sci. (1993) 18(Suppl ):1-9.
   PubMedGoogle Scholar
• BOUMIZA R, DEBARD AL, MONNERET G: The basophil activation test by flow cytometry: recent developments in clinical studies, standardization and emerging perspectives. Clin. Mol. Allergy. (2005) 3(9):1-8.
   PubMedGoogle Scholar
• BENOIT Y, CHADENSON O, DUCLOUX B et al.: Hypersensitivity reactions to Althesin infusion: measurement of complement involvement. Anaesthesia. (1983) 38(11):1079-1081.
   PubMed Web of Science ®Google Scholar
• DESCOTES J: Autoimmunity and toxicity testing. Toxicol Lett. (2000) 112-113(1):461-465.
   PubMed Web of Science ®Google Scholar
• VERDIER F, PATRIARCA C, DESCOTES J: Autoantibodies in conventional toxicity testing. Toxicology (1997) 119(1):51-58.
   PubMed Web of Science ®Google Scholar
• RAVEL G, DESCOTES J: The popliteal lymph node assay: facts and perspectives. J. Appl. Toxicol. (2005) 25(6):451-458.
   PubMed Web of Science ®Google Scholar
• VIAL T, CARLEER J, LEGRAIN B, VERDIER F, DESCOTES J: The popliteal lymph node assay: results of a preliminary interlaboratory validation study. Toxicology (1997) 122(3):213-218.
   PubMed Web of Science ®Google Scholar
• PIETERS R, EZENDAM J, BLEUMINKR, BOL M, NIERKENS S: Predictive testing for autoimmunity. Toxicol Lett. (2002) 127(1-3):83-91.
   PubMed Web of Science ®Google Scholar
• BUHLES WC: Application of immunologic methods in clinical trials. Toxicology (1998) 129(1):73-89.
   PubMed Web of Science ®Google Scholar
• BIAGINI RE: Epidemiology studies in immunotoxicity evaluations. Toxicology (1998) 129(1):37-54.
   PubMed Web of Science ®Google Scholar
• NATIONAL RESEARCH COUNCIL: Biologic Markers in Immunotoxicology. National Academy Press, Washington DC, USA (1992).
   Google Scholar
• STRAIGHT JM, KIPEN HM, VOGT RF, AMLER RW: Immune Function Test Batteries for Use in Environmental Health Field Studies. Agency for Toxic Substances and Diseases Registry, Atlanta, US (1994).
   Google Scholar